Sign In

These evidence-based guidelines are developed and updated regularly by a committee of experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventative aspects of care.

AASLD provides unrestricted access to the full text guideline PDFs, an option to download summary versions to the following devices, and links to Guideline Central's Pocket Card products.


     

 

 

Alcoholic Liver Disease
August 2014
Ascites due to cirrhosis, management
October 2014
Autoimmune hepatitis, management
October 2014
Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis, management
October 2014
Hepatitis B, Chronic
October 2014
Hepatocellular Carcinoma, management
Liver Biopsy
October 2014
Long-Term Medical Management of the Pediatric Patient After Liver Transplantation
October 2014
Non-alcoholic Fatty Liver Disease, Diagnosis and Management
October 2014
Primary Biliary Cirrhosis
October 2014
Primary Sclerosing Cholangitis, management
October 2014
Vascular Disorders of the Liver
October 2014
Wilson Disease, diagnosis and treatment
October 2014

 

AASLD commissions and provides financial support for formulation and production of Practice Guidelines by volunteer experts. Financial support from commercial entities or the pharmaceutical industry is not accepted for the development of AASLD practice guidelines. However, independent medical educational grants are permitted for the distribution of mobile download applications.

These evidence-based guidelines are developed and updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. AASLD strives to review and update its Practice Guidelines every five (5) years, as necessary. Users are cautioned that in the interim, scientific and medical developments may supercede or invalidate, in whole or in part, specific recommendations in any Guideline. A Guideline is considered to be "inactive" if it has not been updated by AASLD in at least five (5) years, and for this reason particular care must be exercised in placing reliance on an inactive Guideline.

Guidelines Development Policies

AASLD Practice Guidelines are copyright protected. One copy may be accessed for personal research, scientific, scholarly or informational purposes and may be transmitted to a third-party colleague in hard copy or electronically for similar use. One figure, table or brief excerpt less than 400 words may be used in one’s scientific, scholarly and educational work with appropriate credit. Permission is required to reproduce more than one figure, table, or section over 400 words or complete practice guidelines and position papers for systematic redistribution. Re-sale and posting AASLD practice guidelines on other websites are not allowed; however, linking to AASLD guidelines is permitted. Please contact adavisowino@aasld.org for assistance.

Update to Recommendations for Testing, Managing, and Treating Hepatitis C

AASLD and the Infectious Diseases Society of America (IDSA), in collaboration with the International Antiviral Society-USA (IAS-USA), released an update to the Recommendations for Testing, Managing, and Treating Hepatitis C on www.hcvguidelines.org.

AASLD Position on Treating Patients with Chronic Hepatitis C Virus

AASLD has always put the patient first by providing clinicians with the latest rigorous data on the best treatments for patients with liver diseases, including hepatitis C.

Read AASLD's position.